Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity - implications for engraftment of human cells

Immunology

Volumn 143, Issue 1, 2014, Pages 61-67

  Kwong, Lai Shan ^a   Brown, Marion H ^a   Barclay, A Neil ^a   Hatherley, Deborah ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD47; Myeloid; SIRP ; Xenotransplantation

Indexed keywords

CD47 ANTIGEN; CELL SURFACE PROTEIN; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CD47; MYELOID; SIRP Α; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD47; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, IMMUNOLOGIC; SURFACE PLASMON RESONANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84904888812     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12290     Document Type: Article

References (31)

1. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 2012; 12:786-98.
2. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8:1313-23.
3. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science 2000; 288:2051-4.
4. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006; 6:457-64.
5. Barclay AN, van den Berg TK. The interaction between Signal Regulatory Protein Alpha (SIRPα) and CD47 - structure, function and therapeutic target. Annu Rev Immunol 2014; 32:25-50.
6. Chao MP, Weissman IL, Majeti R. The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 2012; 24:225-32.
7. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr, van Rooijen N, Weissman IL. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009; 138:286-99.
8. Weiskopf K, Ring AM, Ho CC et al. Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Science 2013; 341:88-91.
9. Zhao XW, van Beek EM, Schornagel K et al. CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction. Proc Natl Acad Sci USA 2011; 108:18342-7.
10. Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001; 11:130-5.
11. Oldenborg PA. CD47: a cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease. ISRN Hematol 2013; 2013:614619.
12. Theocharides AP, Jin L, Cheng PY et al. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J Exp Med 2012; 209:1883-99.
13. Sano S, Ohnishi H, Kubota M. Gene structure of mouse BIT/SHPS-1. Biochem J 1999; 344:667-75.
14. Yamauchi T, Takenaka K, Urata S et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013; 121:1316-25.
15. -/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci USA 2011; 108:13218-23.
16. Legrand N, Huntington ND, Nagasawa M et al. Functional CD47/signal regulatory protein α (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci USA 2011; 108:13224-9.
17. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990; 18:5322.
18. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998; 188:2083-90.
19. Hatherley D, Graham SC, Turner J, Harlos K, Stuart DI, Barclay AN. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell 2008; 31:266-77.
20. Hatherley D, Barclay AN. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol 2004; 34:1688-94.
21. Peiser L, Gough PJ, Kodama T, Gordon S. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun 2000; 68:1953-63.
22. Aricescu AR, Lu W, Jones EY. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 2006; 62:1243-50.
23. Barclay AN, Hatherley D. The counterbalance theory for evolution and function of paired receptors. Immunity 2008; 29:675-8.
24. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 2013; 339:971-5.
25. Hatherley D, Lea SM, Johnson S, Barclay AN. Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47. J Biol Chem 2014; 289:10024-8.
26. Foster-Cuevas M, Westerholt T, Ahmed M, Brown MH, Barclay AN, Voigt S. Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor. J Virol 2011; 85:6055-9.
27. Foster-Cuevas M, Wright GJ, Puklavec MJ, Barclay AN. Human Herpesvirus-8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol 2004; 78:7667-76.
28. Hatherley D, Lea SM, Johnson S, Barclay AN. Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure 2013; 21:820-32.
29. Akkaya M, Aknin ML, Akkaya B, Barclay AN. Dissection of agonistic and blocking effects of CD200 receptor antibodies. PLoS ONE 2013; 8:e63325.
30. null cells. Proc Natl Acad Sci USA 2007; 104:13744-9.
31. -/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood 2013; 122:4013-20.